CORONA Remedies to Participate in Investor Conferences on Feb 23-24, 2026
CORONA Remedies Limited will attend investor conferences on February 23 and 24, 2026, in Mumbai. The meetings are hosted by Kotak Institutional Equities Group and IIFL Capital Group. Discussions will be limited to publicly available information.
The announcement is an intimation of participation in investor meetings and does not involve any new financial commitments, strategic decisions, or material business developments that would significantly impact the company's operations or stock price.
The announcement is a routine disclosure of participation in investor meetings and does not contain any new financial information or significant business updates that would sway the sentiment.
CORONA Remedies Limited announced its participation in two upcoming investor conferences hosted by Kotak Institutional Equities Group and IIFL Capital Group. The meetings are scheduled to take place in Mumbai.
On Monday, February 23, 2026, starting from 10:00 AM IST, company officials will attend 1x1 meetings organized by Kotak Institutional Equities Group. Subsequently, on Tuesday, February 24, 2026, also from 10:00 AM IST, the company will participate in meetings hosted by IIFL Capital Group.
Discussions during these conferences will be based solely on publicly available information, and no unpublished price-sensitive information (UPSI) will be disclosed. The company noted that the schedule is subject to change due to unforeseen circumstances.
What to do with a filing like this
CORONA Remedies Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CORONA Remedies Limited. Read the original for the full detail.